Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Eissing

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Bio Systems|February 23, 2007
Steady state and (bi-) stability evaluation of simple protease signalling networksThomas Eissing, Steffen Waldherr, Frank Allgöwer, et al.
Clinical Pharmacology and Therapeutics|April 11, 2018
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published ModelsAndré Dallmann, Marc Pfister, John van den Anker, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 16, 2021
Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenoneThomas Wendl, Sebastian Frechen, Michael Gerisch, et al.
Clinical Pharmacokinetics|September 20, 2017
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic PathwaysAndré Dallmann, Ibrahim Ince, Katrin Coboeken, et al.
Translational Vision Science & Technology|May 18, 2021
Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical OutcomesThomas Eissing, Michael W Stewart, Cynthia X Qian, et al.
Frontiers in Pharmacology|June 5, 2012
Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass BalanceKristin Dickschen, Stefan Willmann, Kirstin Thelen, et al.
Clinical Pharmacokinetics|April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in PregnancyAndré Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after deliveryAndré Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2012
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug developmentAshley Strougo, Thomas Eissing, Ashraf Yassen, et al.
Springerplus|June 18, 2014
Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modelingKristin Dickschen, Thomas Eissing, Thomas Mürdter, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Bio Systems|February 23, 2007
Steady state and (bi-) stability evaluation of simple protease signalling networksThomas Eissing, Steffen Waldherr, Frank Allgöwer, et al.
Clinical Pharmacology and Therapeutics|April 11, 2018
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published ModelsAndré Dallmann, Marc Pfister, John van den Anker, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 16, 2021
Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenoneThomas Wendl, Sebastian Frechen, Michael Gerisch, et al.
Clinical Pharmacokinetics|September 20, 2017
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic PathwaysAndré Dallmann, Ibrahim Ince, Katrin Coboeken, et al.
Translational Vision Science & Technology|May 18, 2021
Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical OutcomesThomas Eissing, Michael W Stewart, Cynthia X Qian, et al.
Frontiers in Pharmacology|June 5, 2012
Physiologically Based Pharmacokinetic Modeling of Tamoxifen and its Metabolites in Women of Different CYP2D6 Phenotypes Provides New Insight into the Tamoxifen Mass BalanceKristin Dickschen, Stefan Willmann, Kirstin Thelen, et al.
Clinical Pharmacokinetics|April 13, 2017
Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in PregnancyAndré Dallmann, Ibrahim Ince, Michaela Meyer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 5, 2020
Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after deliveryAndré Dallmann, Anneke Himstedt, Juri Solodenko, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 8, 2012
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug developmentAshley Strougo, Thomas Eissing, Ashraf Yassen, et al.
Springerplus|June 18, 2014
Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modelingKristin Dickschen, Thomas Eissing, Thomas Mürdter, et al.
Pageof 5